3-Methyl-PCPy: Difference between revisions
CSV import |
CSV import |
||
| Line 3: | Line 3: | ||
[[File:3-Me-PCPy_Structure.svg|thumb|right|Chemical structure of 3-Methyl-PCPy]] | [[File:3-Me-PCPy_Structure.svg|thumb|right|Chemical structure of 3-Methyl-PCPy]] | ||
'''3-Methyl-PCPy''' is a chemical compound that belongs to the class of [[arylcyclohexylamines]]. It is a derivative of [[ | '''3-Methyl-PCPy''' is a chemical compound that belongs to the class of [[arylcyclohexylamines]]. It is a derivative of [[PCP (phencyclidine)]], which is known for its [[dissociative anesthetic]] properties. The addition of a methyl group to the PCP structure results in 3-Methyl-PCPy, which has been studied for its pharmacological effects and potential applications in neuroscience research. | ||
== Chemical Structure == | == Chemical Structure and Properties == | ||
3-Methyl-PCPy is | 3-Methyl-PCPy is characterized by the presence of a cyclohexylamine core with an aryl group attached. The chemical structure is similar to that of PCP, with the key difference being the addition of a methyl group at the 3-position of the cyclohexyl ring. This modification can influence the compound's binding affinity and activity at various [[neurotransmitter receptors]]. | ||
== Pharmacology == | == Pharmacology == | ||
3-Methyl-PCPy acts primarily as an [[NMDA receptor antagonist]] | 3-Methyl-PCPy acts primarily as an [[NMDA receptor antagonist]], similar to other compounds in the arylcyclohexylamine class. By blocking the NMDA receptor, it can disrupt normal synaptic transmission, leading to its characteristic dissociative effects. This mechanism of action is shared with other dissociative anesthetics such as [[ketamine]] and [[dextromethorphan]]. | ||
== Effects == | === Effects === | ||
The effects of 3-Methyl-PCPy are | The effects of 3-Methyl-PCPy are similar to those of PCP, including altered perception, [[hallucinations]], and [[analgesia]]. The compound can induce a state of dissociation, where users feel detached from their body and environment. These effects make it a subject of interest in the study of [[consciousness]] and [[psychiatric disorders]]. | ||
== | == Research Applications == | ||
Due to its action on the NMDA receptor, 3-Methyl-PCPy is used in research to study the role of glutamatergic systems in the brain. It is particularly useful in modeling conditions such as [[schizophrenia]] and [[neurodegenerative diseases]], where NMDA receptor dysfunction is implicated. | |||
== | == Safety and Legal Status == | ||
3-Methyl-PCPy is | As with many compounds in the arylcyclohexylamine class, 3-Methyl-PCPy may pose risks of [[neurotoxicity]] and [[addiction]]. Its legal status varies by country, and it is often subject to regulation due to its potential for abuse and lack of approved medical use. | ||
== Related Pages == | |||
== | |||
* [[Phencyclidine]] | |||
* [[NMDA receptor antagonist]] | * [[NMDA receptor antagonist]] | ||
* [[Dissociative | * [[Dissociative anesthetic]] | ||
* [[Arylcyclohexylamine]] | * [[Arylcyclohexylamine]] | ||
[[Category:Arylcyclohexylamines]] | [[Category:Arylcyclohexylamines]] | ||
[[Category:Dissociative drugs]] | [[Category:Dissociative drugs]] | ||
Latest revision as of 11:06, 15 February 2025
3-Methyl-PCPy[edit]
3-Methyl-PCPy is a chemical compound that belongs to the class of arylcyclohexylamines. It is a derivative of PCP (phencyclidine), which is known for its dissociative anesthetic properties. The addition of a methyl group to the PCP structure results in 3-Methyl-PCPy, which has been studied for its pharmacological effects and potential applications in neuroscience research.
Chemical Structure and Properties[edit]
3-Methyl-PCPy is characterized by the presence of a cyclohexylamine core with an aryl group attached. The chemical structure is similar to that of PCP, with the key difference being the addition of a methyl group at the 3-position of the cyclohexyl ring. This modification can influence the compound's binding affinity and activity at various neurotransmitter receptors.
Pharmacology[edit]
3-Methyl-PCPy acts primarily as an NMDA receptor antagonist, similar to other compounds in the arylcyclohexylamine class. By blocking the NMDA receptor, it can disrupt normal synaptic transmission, leading to its characteristic dissociative effects. This mechanism of action is shared with other dissociative anesthetics such as ketamine and dextromethorphan.
Effects[edit]
The effects of 3-Methyl-PCPy are similar to those of PCP, including altered perception, hallucinations, and analgesia. The compound can induce a state of dissociation, where users feel detached from their body and environment. These effects make it a subject of interest in the study of consciousness and psychiatric disorders.
Research Applications[edit]
Due to its action on the NMDA receptor, 3-Methyl-PCPy is used in research to study the role of glutamatergic systems in the brain. It is particularly useful in modeling conditions such as schizophrenia and neurodegenerative diseases, where NMDA receptor dysfunction is implicated.
Safety and Legal Status[edit]
As with many compounds in the arylcyclohexylamine class, 3-Methyl-PCPy may pose risks of neurotoxicity and addiction. Its legal status varies by country, and it is often subject to regulation due to its potential for abuse and lack of approved medical use.
